
Y-mAbs Announces Presentation of Naxitamab data at AACR 18 April 2023
NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
NEW YORK, April 18, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
Participate now in The Danish Biotech Salary Survey to find out. Finding the right balance between salary... Read more
NEW YORK, April 05, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
Q4 2022 DANYELZA® record net product revenues of $16.4 million, driving YoY growth of 71% and 31%... Read more
Oslo Norway, March 23, 2023 Today LINK Medical has announced the integration of Pharm Assist into the... Read more
NEW YORK, March 21, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
Finding the right balance between salary costs and the ability to attract and retain key talent is crucial... Read more
NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or... Read more
Genève og Erlangen – 2. februar 2023: Unilabs, en førende udbyder af diagnostiske services, og Siemens... Read more